结直肠癌:通过涉及致癌的分子途径探索预测生物标志物
Sheila Martins1, Pedro Veiga2, José Guilherme Tralhão2,3,4,5
1Portuguese Oncology Institute of Coimbra, 3000-075 Coimbra, Portugal.
Biology
|January 8, 2025
概括
结肠直肠癌 (CCR) 是2022年欧洲第二常见的癌症. 早期发现和预防策略对于减少这种疾病的影响至关重要.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 结肠直肠癌 (CCR) 是欧洲的一个重大公共卫生问题.
- 在2022年,CCR在乳腺癌之后,成为该地区第二大被诊断的癌症.
研究的目的:
- 分析欧洲结直肠癌的发病率和趋势.
- 突出结直肠癌带来的公共卫生负担.
主要方法:
- 流行病学数据分析.
- 欧洲国家癌症发病率统计数据的综述.
主要成果:
- 结肠直肠癌 (CCR) 在2022年在欧洲显示出第二高的发病率.
- 乳腺癌是唯一具有更高发病率的癌症.
结论:
- 结直肠癌 (CCR) 的高发病率凸显了加强查和预防计划的必要性.
- 持续的监测和研究对于打击欧洲结直肠癌的负担至关重要.
相关概念视频
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
01:25Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K